The potential of a large variety of new compounds and new strategies for the treatment of
virtually all major virus infections has been addressed. This includes, for the treatment of HIV …

Prominent in the current stage of antiviral drug development are:(i) for human
immunodeficiency virus (HIV), the use of fixed‐dose combinations (FDCs), the most recent …

Antiviral Drugs - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI
Homepage MyNCBI Homepage Main Content Main Navigation Preview improvements coming …

This book focuses on new small molecule approaches to combat viral infections. The
chapters describe the discovery and development from bench through the clinic of relatively …

Viral infections cause high morbidity and mortality, threaten public health, and impose a
socioeconomic burden. We have seen the recent emergence of SARS‐CoV‐2 (Severe …

Three decades of antiviral drugs | Nature Reviews Drug Discovery Skip to main content Thank
you for visiting nature.com. You are using a browser version with limited support for CSS. To …

The successful development of antiviral drugs is highly dependent on a close interaction
and collaboration between the chemist and the biologist (biomedic). This is illustrated by a …

There are now exactly 20 anti-HIV drugs licenced (approved) for clinical use, and> 30 anti-
HIV compounds under (pre) clinical development. The licenced anti-HIV drugs fall into five …

This review article that complements the previous review article on “The discovery of
antiviral agents: ten different compounds, ten different stories” presents ten more …

Virtually all the compounds that are currently used, or under advanced clinical trial, for the
treatment of HIV infections, belong to one of the following classes:(i) nucleoside/nucleotide …